A fast and efficient multiresidue extraction-purification procedure was developed for low levels (ppb range) of phenanthrene and hydroxyphenanthrene in biological matrices, in order to quantify phenanthrene and metabolites in blood, milk, urine, and biological tissues of lactating goats. Detection and identification of the analytes (phenanthrene and 1-, 2-, 3-, 4-, and 9-hydroxyphenanthrene) were achieved using gas chromatography coupled to mass spectrometry. Deuterium-labeled phenanthrene was used as internal standard for phenanthrene and 2-OHfluorene for metabolites. The developed method includes enzymatic hydrolysis, liquid-liquid extraction, and Envi-Chrom P SPE column purification. Analyses were performed in the selected ion monitoring mode to achieve ad hoc sensitivity in accordance with analyte concentrations in food samples. Detection limits were between 2.3 and 5.1 ng/mL (ppb) for milk samples, 0.5 and 2.5 ng/mL for urine and blood samples, and 1.9 and 8.0 ng/g for tissue samples. This original multiresidue and multimatrix analytical methodology was applied to metabolism studies and polycyclic aromatic hydrocarbon (PAH) risk assessment. We demonstrated, for the first time, that metabolites were present in milk. These results suggested that usual PAHs analysis methods based on the detection of native molecule are not representative of the real contamination of biological matrices.
Introduction
Phenanthrene occurs in fossil fuels and is present in products of incomplete combustion. Some of the known sources of phenanthrene in the atmosphere are vehicular emissions, coal and oil burning, wood combustion, coke plants, aluminium plants, and steel works (1) . Phenanthrene is widely distributed in the environment and has been identified in ambient air, drinking water, and foods (2) . Physical and chemical properties of poiycyclic aromatic hydrocarbons (PAils) explain their migration through food chain with hydrophobic compartments and then their accumulation in lipids at the end of the chain (3, 4) .
Phenanthrene is one of the PAHs on the U.S. Environmental Protection Agency's priority list. PAHs present generally a high lipophilicity and can cross through skin and/or mucous membranes (1) . Recent data suggest that phenanthrene would be absorbed readily from the gastrointestinal tract and transferred through lungs (5, 6) . Phenanthrene wag detected in the blood of pigs 1-3 h after ingestion of milk spiked with 14-C phenanthrene (7) . Moreover, after absorption in the body, phenanthrene is either distributed in tissues (liver and kidney) (8) or accumulated in adipose tissue (9) and may be excreted in milk (10, 11) . In addition, PAHs are largely excreted in urine as hydroxylated metabolites (12, 13) . In vivo and in vitro studies indicated that metabolism proceeds via epoxidation at the 1-2, 3-4, and 9-10 positions, with dihydroxyphenanthrene and hydroxyphenanthrene as metabolites: 9-10 dihydroxyphenanthrene as major component. The 9-10, 1-2, and 3-4 dihydrodiols of phenanthrene have been found either conjugated or not conjugated in urine of rat and guinea pig (14) . Glucuronidation of 1-, 2-, 3-, 4-, and 9-hydroxyphenanthrene has been demonstrated as well (14) . In vitro studies with guinea monogastric animal liver preparations also identified the 9-10, 1-2, and 3-4 dihydrodiols. Further oxidative metabolism to the 9,10-oxide and 1,2-diol-3,4-epoxide of phenanthrene has also been reported (15, 16) .
Whereas few data exist about PAHs occurrence in cow milk (8, (10) (11) (12) (13) (14) (15) (16) (17) 18) , no data are available about phenanthrene metabolites in this staple food.
Thus, our purpose was to develop a general method for phenanthrene and its metabolites (hydroxyphenanthrenes) in various biological matrices (milk samples in particular) at low residue level. The analytical method was finally applied to various biological matrices collected from phenanthrene treated animal.
Experimental

Reagents and chemicals
Most of reagents and solvents (acetic acid, acetonitrile, n-dodecan, cyclohexane, ethyl acetate, methanol, and toluene) were of analytical grade quality and were provided by Solvents Documentation Synthesis (SDS, Peypin, France) and Sigma (St.-Quentin-Fallavier, France). Helix pomatia juice was furnished by Biosepra (Villeneuve la Garenne, France). The solid-phase extraction (SPE) columns (styrene-divinylbenzene copolymer resin, Envi Chrom P, 0.5 g) were from Supelco (St.-QuentinFallavier, France). The derivatization reagent N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) was purchased from Fluka (Buchs, Switzerland).
Standards references (Table I and Figure 1 ) 1-, 2-, 3-, 4-, and 9-hydroxyphenanthrene were from Chiron (Trondheim, Norway); phenanthrene, 1-hydroxypyrene, and 2-hydroxyfluo- rene were obtained from Sigma Aldrich (St.-Quentin-Fallavier, France); and phenanthrene-dl0 was from Interchim (Montlu~;on, France). Standard solutions were prepared at 1 mg/mL in toluene for 1-, 2-, 3-, 4-, and 9-hydroxyphenanthrene and in methanol for phenanthrene. Working solutions were prepared monthly by 10-fold successive dilutions at concentrations from 100 ng/IJL to 1 ng/IJL and were stored at -20~ Phenanthrene-dl0 and 2-hydroxyfluorene internal standard solutions were prepared at 1 ng/IJL in methanol and in acetonitrile, respectively; 1-hydroxypyrene external standard solution was prepared at 1 ng/tJL in acetonitrile.
Phenanthrene administration and sampling
The animal protocol was in accordance with the general guidelines of the Council of European Communities (1986, No. 86/609/CEE) and the French Animal Care Guidelines. Biological samples from an untreated goat were used as blanks, and four Alpine goats (2-3 years old and 50 _+ 5 kg) from the herd of "Domaine Experimental de la Bouzule" (Champenoux, France) were used for this experiment. They benefited from a seven-day adaptation period within individual metabolic cages. Ambient temperature was close to 22~ and natural light conditions prevailed. Each goat was fitted with a temporary polyvinyl chloride intravenous catheter (Vialon Becton Dickinson, te Pont-De-Claix, France) and urinary catheter (Eschmann Healthcare, West Sussex, England). Each animal was received a single oral dose of phenanthrene (200 rag) diluted in 2 mL of vegetable oil (ISIO 4, Lesieur, Neuilly-sur-Seine, France) directly in the mouth with a syringe. The syringe was then flushed twice with 2 mL of vegetable oil that was given to the animals. A total of 6 mL oil was ingested by each animal; this quantity should not have any effect on rumen activity (19) . Milk, blood, and urine samples were collected twice each day (at 8 a.m. and 5 p.m. for five days). Finally, after a five-day period, the goats were anesthetized and sacrified; organs and tissues (liver, longissimus dorsi muscle, kidney) were collected. Blood, excretion products and tissue samples were stored frozen below -18~ Thus, incurred samples were an excellent biological tool to identify metabolites in different matrices. 
Gas chromatographic-mass spectrometric (GC-MS) analysis
The quadrupole MS (HP-5989) system used was coupled to an HP-5890 GC, both from Hewlett-Packard (Palo Alto, CA). The split/ splitless injector was maintained at 250~ the time of splitless mode was set at 1.5 rain, and the injected volume was 2 tJL. The column used for the separation of phenanthrene and its metabolites was an OV-1 (OhioValley, 30 m • 0.25-ram i.d., 0.25-1Jm film thickness). The GC parameters used on the column were 120~ (2 rain), 10~ until 200~ 5~ until 250~ then 15~ until 300~ (3 rain). Helium (N55) was used as carrier gas at 1 mL/min flow. The electronic beam energy on the spectrometer was set at 70 eV in the electron impact mode. Chromatograms in relation to the developed procedure were total ion chromatograms ( Figures 2 and 3 ). The chromatograms corresponding to samples analysis were performed in selected ion monitoring mode in order to attain sensitivities in accordance with blood, milk, urine, and tissue sample contaminant concentrations (Figures 4-7 ). Molecular ion 266 and its major fragments 251, 235, and 165 were monitored for each hydroxyphenanthrene. For phenanthrene molecular ion 178 and its major fragments 152 and 89 were screened. The detail list of ions monitored for internal and external standards are described in Table I .
Extraction-purification
The developed procedure for the extraction-purification of phenanthrene and its metabolites in the different investigated matrices (blood, milk, urine, liver, kidney, and longissimus dorsi muscle) is represented in Figure 8 . Tissue sample (1 g) was lyophilized and ground into powder. Ten milliliters acetate buffer (0.2M, pH 5.2), 400 pL internal standards at 1 ng/l~L (phenanthrene-d~0 and 2-OHfluorene), and 150 pL of a purified Helix pomatia preparation containing 25 units/laL were added to tissue or blood sample (10 mL), and the hydrolysis of conjugated metabolites was carried out at 37~ for 16 h. Liquid-liquid extraction, with 10 mL ethyl acetate and 10 mL cyclohexane, allowed the extraction of both phenanthrene and hydroxyphenanthrene. After stirring (30 rain) and centrifugation (5500 rpm, 20 rain), supernatant was collected, 200 pL n-dodecane was added, and solvents were evaporated at 37~ using N2. The residue was dissolved in 3 mL cyclohexane and applied onto a Envi-Chrom P SPE column previously conditioned with cyclohexane. After elution of interfering compounds with 3 mL cyclohexane, phenanthrene and 1-, 2-, 3-, 4-, and 9-OH phenanthrene were eluted with 12 mL cyclohexane/ethyl acetate (50:50; v/v). Fourhundred microliters of I ng/l~L external standard (1-OH pyrene) solution was added. After evaporation to dryness (at 37~ using N2), the extract was reconstituted in 20 I~L of MSTFA, and total derivatization of target analytes was achieved after 40 rain at 30~ Two microliters was injected onto the GC-MS. For milk and urine samples (10 mL), the pH of the aqueous phase was neutralized by the respective additions of 40 and 100 pL glacial acetic acid, and the samples 18 
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were hydrolyzed and purified according to the procedure described herein.
Results and Discussion
Biological preparation
Before any treatment of solid samples, freeze-drying was applied. This technique was preferred to enzymatic digestion (20), matrix solid phase dispersion (21), or solvent extraction of the fresh sample. Indeed, lyophilization permitted grinding of the sample into fine powder, resulting in increased interaction between sample and solvent. Better extraction yield was observed. Regarding blood, addition of 10 mL acetate buffer (0.2M) was necessary to avoid coagulation during deconjugation and to keep the pH constant during 16 h of hydrolysis. Milk and urine were used directly after defrosting without any preparative step.
Deconjugation
Enzymatic hydrolysis of conjugated PAH metabolites in urine using Helix pomatia juice was used in the method because a significant proportion of PAH residues are glucurono-or sulfo-conjugated (15). The total quantity of 1-, 2-, 3-, 4-, and 9-OHphenanthrene determined with or without Helix pomatia deconjugation was evaluated on inccurred samples. In urine, the chromatograms in Figure 2A show that deconjugation gives an increase of approximately 90% in the yield of 1-,3-,4-OHphenanthrene but only a slight increase of approximately 4% in the case of 2-and 9-OHphenanthrene; this observation underscores the necessity of such a hydrolysis step for further quantitative determination of PAH. In milk, chromatograms in Figure 2B show that deconjugation permits observation of target hydroxy-metabolites that appeared to be fully conjugated.
Optimization of extraction conditions
To evaluate the efficiency of extraction methods, the extractability of phenanthrene and 1-, 2-, 3-, 4-, and 9-OHphenanthrene through out the entire procedure was determined using spiked urine or milk samples. Liquid-liquid extractions using acetone, ethyl acetate, dichloromethane, hexane, and cydohexane were compared. Significant differences in the extractibility of standard phenanthrene and 1-, 2-, 3-, 4-, and 9-hydroxyphenanthrene spiked were observed.
Because of the recovery yield for phenanthrene and hydroxyphenanthrene and chromatogram quality, the cyclohexane/ethyl acetate (50:50, v/v) mixture was retained for further use.
Purification of phenanthrene and hydroxyphenanthrene compounds
A chromatographic SPE system combining cyclohexane/ethyl acetate (50:50, v/v) as mobile phase with Envi Chrom P as stationary phase was selected for phenanthrene and hydroxyphenanthrene compounds purification. All compounds were eluted with 12 mL cyclohexane/ethyl acetate (50:50, v/v). This first step increased extraction selectivity without affecting recovery yield (43% in milk, 87% in urine, and 59% in blood and tissue, n = 6).
Derivatization
A different derivatization procedure was tested for all compounds. Two derivatization reagents were compared: MSTFA/TMIS/DTE (1000:5:5, v/v/w) and MSTFA. In Figure 3 , MSTFA/TMIS/DTE was found to generate more intense interferences and less resolution, especially for urine and milk samples. Moreover, because aromatic alcohols have to be derivatized, a weak silating reagent appears sufficient. MSTFA was finally selected for 1-, 2-, 3-, 4-, and 9-OHphenanthrene compounds.
Validation
The limit of detection was evaluated on the measurement of eight blank samples spiked with 40 ng/mL of each compound. The detection limit calculated with spiked samples on m/z 266 was 2.3-5.1 ng/mL (ppb) range for milk samples, 0.5-2.5 ng/mL for urine and blood samples, and 1.9-8.0 ng/g for tissue samples. At those limit of detections, spiked samples permitted a distinguishable signalto-noise ratio of greater than 3. Extraction repeatability was evaluated on the basis of eight spiked samples at 40 ng/mL and analyzed the same day by the same operator only for urine and milk, which appeared to be the most interesting matrices for our study. For phenanthrene and its metabolites, repeatability was found between 12.9% and 19.3% in urine and between 9.9% and 26.8% in milk. Calibration curves in milk were performed daily over the 4 days using blank and 5, 10, 15, and 25 ng/mL for phenanthrene and 1-, 2-, and 4-OHphenanthrene, and 15, 30, 45, and 60 ng/mL for 3-and 9-OHphenanthrene. The determination coefficient (R 2) was 0.903 for phenanthrene and varied within the 0.969 and 0.996 range for hydroxylated phenanthrene. In urine, calibration curves were achieved with phenanthrene spike samples at 0.0, 0. Ion chromatograms for spiked and incurred samples illustrate four different matrices ion chromatograms for phenanthrene and hydroxylated phenanthrene corresponding to treated animals. In each case, three different samples were analyzed: trace A shows the spiked sample at 40 ng/mL, trace B represents the blank sample, and trace C was obtained from incurred samples. The highest contaminated samples were shown systematically. Figure 4 illustrates the signal for phenanthrene (m/z 178; 9.57 min) and 1-, 2-, 3-, 4-, and 9-hydroxyphenanthrene (rn/z 266; 12.90, 13.58, 13.81, 13.90, and 14.29 min, respectively) in blood sample. The molecular ion chromatogram is very specific for all analytes; the measured signal-to-noise ratio in spiked sample was 24 for phenanthrene and between 90 and 200 for hydroxyphenanthrene. Phenanthrene and sum hydroxylated phenanthrene levels were detected in incurred blood samples (trace C) at concentrations estimated to be 2.3 and 611.1 ppb, respectively. Compared to the spiked sample chromatograms (trace A), phenanthrene and 1-OHphenanthrene were not detected at this stage of the kinetic (7 h after administration); they appeared more clearly after 22 h. A rapid transfer from feed to blood of phenanthrene has been noticed. Three hours after ingestion, concentrations of 3-, 4-, and 9-OHphenan- threne in blood were at their highest levels, and a very fast absorption and metabolization of the molecule occurred.
Concerning milk, Figure 5 shows characteristic ion chromatograms for each group of molecules, the measured signalto-noise ratio is 53.0 for phenanthrene and between 23.4 and 40.0 for hydroxyphenanthrene. In the spiked sample, the highest phenanthrene (17.5 ppb) and sum hydroxyphenanthrene (157.4 ppb) levels were detected 7 h after the oral phenanthrene ingestion. 3-OHPhenanthrene was detected as the most important excreted metabolite in milk.
Measured signal-to-noise ratio of compounds in urine is 110 for phenanthrene and between 50 and 150 for hydroxyphenanthrene. Characteristic ion chromatograms for phenanthrene and its metabolites were presented in Figure 6 . The analyte signals were not disturbed by any interference at the expected retention time. The five hydroxylated phenanthrenes were detected. Phenanthrene shows a low excretion in urine (27.7 ppb) at 7 h and during the whole experimental period, contrarily to the sum of its metabolites concentrations (8624.3 ppb). We noticed that phenanthrene was detected in blank sample (trace B); its presence was representative of environmental contamination. 2-OHPhenanthrene and 3-OHphenanthrene appeared to be the most important excreted metabolites in urine.
Finally, Figure 7 illustrates the analysis of kidney tissue: measured signal-to-noise ratio is 65 for phenanthrene and range 15 to 70 for hydroxyphenanthrene. Phenanthrene and sum hydroxytated phenanthrene levels were detected in kidney incurred sample (trace C) at a concentration estimated to 392 and 1515 ng/g, respectively. Phenanthrene and 9-OHphenanthrene were detected as major compounds in this matrix. We can see that phenanthrene and 9-OHphenanthrene were detected in blank (trace B), and their presences were representative of environmental levels.
Conclusions
The objective of this work was to develop an efficient extraction-purification procedure for phenanthrene and hydroxyphenanthrene in milk, urine, blood, and biological tissue samples. PAH lipophilic characteristic was exploited both throughout extraction and purification methods. The proposed method detection limits were between 2.3 and 5.1 ng/mL (ppb) in milk, 0.5 and 2.5 ng/mL (ppb) in urine and blood, and 1.9 and 8.0 ng/g (ppb) in tissue. The method was tested for its applicability to metabolite profile determination in different incurred matrices (blood, milk, urine, and biological tissue). Although not optimized, the method exhibits satisfactory separation of all metabolites under investigation without any interfering signals.
This method was ensured to give a new insight on phenanthrene and hydroxyphenanthrene presence in various biological samples (milk, urine, blood, and tissue). It is the first time that metabolites were detected and described (identified) in milk. This result suggests that usual methods of detection of PAHs based on the detection of native molecules are not representative of the real contamination of biological matrix in en-vironment. This original multiresidue and multimatrices analytical methodology will be used for further metabolism studies and risk assessment. It should be applicable to the monitoring of phenanthrene and metabolites in humans or animals for toxicological studies. In addition, this method might be useful for estimating the prevalence of phenanthrene and its metabolites in food samples.
This study also revealed that in milk PAHs metabolites are mainly conjugated. The question arising is how to characterize the fate of these conjugated metabolites in term of human absorption and toxicology.
